AMRN Q2 2022 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$94M-38.9% YoY

Gross Profit

$44M46.2% margin

Operating Income

-$63M-66.5% margin

Net Income

-$70M-74.1% margin

EPS (Diluted)

$-3.51

QoQ Revenue Growth

-0.2%

Cash Flow

Operating Cash Flow

-$64M

Free Cash Flow

-$64M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$973M

Total Liabilities

$393M

Stockholders' Equity

$580M

Cash & Equivalents

$228M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$154M	-38.9%
Gross Profit	$44M	$122M	-64.3%
Operating Income	-$63M	$9M	-816.2%
Net Income	-$70M	$8M	-996.0%

Revenue Segments

Product

$94M99%

Licensing And Royalty

$644,0001%